These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 17727896

  • 1. Isoform-specific downregulation of peroxiredoxin in human failing myocardium.
    Brixius K, Schwinger RH, Hoyer F, Napp A, Renner R, Bölck B, Kümin A, Fischer U, Mehlhorn U, Werner S, Bloch W.
    Life Sci; 2007 Aug 16; 81(10):823-31. PubMed ID: 17727896
    [Abstract] [Full Text] [Related]

  • 2. Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines.
    Bae JY, Ahn SJ, Han W, Noh DY.
    J Cell Biochem; 2007 Jul 01; 101(4):1038-45. PubMed ID: 17163455
    [Abstract] [Full Text] [Related]

  • 3. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.
    Skurk C, Wittchen F, Suckau L, Witt H, Noutsias M, Fechner H, Schultheiss HP, Poller W.
    Eur Heart J; 2008 May 01; 29(9):1168-80. PubMed ID: 18390538
    [Abstract] [Full Text] [Related]

  • 4. Peroxiredoxin-4 interacts with and regulates the thromboxane A(2) receptor.
    Giguère P, Turcotte ME, Hamelin E, Parent A, Brisson J, Laroche G, Labrecque P, Dupuis G, Parent JL.
    FEBS Lett; 2007 Aug 07; 581(20):3863-8. PubMed ID: 17644091
    [Abstract] [Full Text] [Related]

  • 5. L-type Ca2+ channel alpha 1c subunit isoform switching in failing human ventricular myocardium.
    Yang Y, Chen X, Margulies K, Jeevanandam V, Pollack P, Bailey BA, Houser SR.
    J Mol Cell Cardiol; 2000 Jun 07; 32(6):973-84. PubMed ID: 10888251
    [Abstract] [Full Text] [Related]

  • 6. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy.
    Szotowski B, Goldin-Lang P, Antoniak S, Bogdanov VY, Pathirana D, Pauschinger M, Dörner A, Kuehl U, Coupland S, Nemerson Y, Hummel M, Poller W, Hetzer R, Schultheiss HP, Rauch U.
    J Am Coll Cardiol; 2005 Apr 05; 45(7):1081-9. PubMed ID: 15808768
    [Abstract] [Full Text] [Related]

  • 7. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M.
    J Heart Lung Transplant; 2008 Jul 05; 27(7):767-74. PubMed ID: 18582807
    [Abstract] [Full Text] [Related]

  • 8. Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning.
    Maack C, Dabew ER, Hohl M, Schäfers HJ, Böhm M.
    Circ Res; 2009 Oct 09; 105(8):811-7. PubMed ID: 19729596
    [Abstract] [Full Text] [Related]

  • 9. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.
    Park JH, Kim YS, Lee HL, Shim JY, Lee KS, Oh YJ, Shin SS, Choi YH, Park KJ, Park RW, Hwang SC.
    Respirology; 2006 May 09; 11(3):269-75. PubMed ID: 16635084
    [Abstract] [Full Text] [Related]

  • 10. The function of peroxiredoxins in plant organelle redox metabolism.
    Dietz KJ, Jacob S, Oelze ML, Laxa M, Tognetti V, de Miranda SM, Baier M, Finkemeier I.
    J Exp Bot; 2006 May 09; 57(8):1697-709. PubMed ID: 16606633
    [Abstract] [Full Text] [Related]

  • 11. Characterization of neural cell types expressing peroxiredoxins in mouse brain.
    Jin MH, Lee YH, Kim JM, Sun HN, Moon EY, Shong MH, Kim SU, Lee SH, Lee TH, Yu DY, Lee DS.
    Neurosci Lett; 2005 Jun 24; 381(3):252-7. PubMed ID: 15896479
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of peroxiredoxin subtypes in human brain cell types.
    Sarafian TA, Verity MA, Vinters HV, Shih CC, Shi L, Ji XD, Dong L, Shau H.
    J Neurosci Res; 1999 Apr 15; 56(2):206-12. PubMed ID: 10494109
    [Abstract] [Full Text] [Related]

  • 13. Determination of P2X1alpha-sarcoglycan (adhalin) expression levels in failing human dilated cardiomyopathic left ventricles.
    Berry DA, Balcar VJ, Barden JA, Keogh A, dos Remedios CG.
    Electrophoresis; 2000 Nov 15; 21(17):3857-62. PubMed ID: 11271504
    [Abstract] [Full Text] [Related]

  • 14. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
    Iwata Y, Ogawa F, Komura K, Muroi E, Hara T, Shimizu K, Hasegawa M, Fujimoto M, Tomita Y, Sato S.
    Rheumatology (Oxford); 2007 May 15; 46(5):790-5. PubMed ID: 17309887
    [Abstract] [Full Text] [Related]

  • 15. Expression of mRNAs and proteins for peroxiredoxins in Plasmodium falciparum erythrocytic stage.
    Yano K, Komaki-Yasuda K, Kobayashi T, Takemae H, Kita K, Kano S, Kawazu S.
    Parasitol Int; 2005 Mar 15; 54(1):35-41. PubMed ID: 15710548
    [Abstract] [Full Text] [Related]

  • 16. Reduction of myocardial myoglobin in bovine dilated cardiomyopathy.
    Weil J, Eschenhagen T, Magnussen O, Mittmann C, Orthey E, Scholz H, Schäfer H, Scholtysik G.
    J Mol Cell Cardiol; 1997 Feb 15; 29(2):743-51. PubMed ID: 9140831
    [Abstract] [Full Text] [Related]

  • 17. Selective activation of N-acyl-D-glucosamine 2-epimerase expression in failing human heart ventricular myocytes.
    Bohlmeyer T, Ferdensi A, Bristow MR, Takahashi S, Zisman LS.
    J Card Fail; 2003 Feb 15; 9(1):59-68. PubMed ID: 12612874
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: effects on cytotoxicity and DNA damage caused by peroxides.
    Banmeyer I, Marchand C, Verhaeghe C, Vucic B, Rees JF, Knoops B.
    Free Radic Biol Med; 2004 Jan 01; 36(1):65-77. PubMed ID: 14732291
    [Abstract] [Full Text] [Related]

  • 19. The Prx Q protein of Arabidopsis thaliana is a member of the luminal chloroplast proteome.
    Petersson UA, Kieselbach T, García-Cerdán JG, Schröder WP.
    FEBS Lett; 2006 Nov 13; 580(26):6055-61. PubMed ID: 17054949
    [Abstract] [Full Text] [Related]

  • 20. Activity assay of mammalian 2-cys peroxiredoxins using yeast thioredoxin reductase system.
    Kim JA, Park S, Kim K, Rhee SG, Kang SW.
    Anal Biochem; 2005 Mar 15; 338(2):216-23. PubMed ID: 15745741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.